Literature DB >> 3733112

Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane.

G B Arden.   

Abstract

In rabbits anaesthetized with urethane, intravenous infusion of the iron-chelating drug desferrioxamine causes a reduction in the amplitude of the electroretinogram. This is most pronounced for weak light intensities, but the change is more complex than a mere reduction in sensitivity. In experiments lasting up to 3 days the effect is reversible and is not accompanied by electron-microscopical histological changes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3733112     DOI: 10.1177/096032718600500403

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  3 in total

1.  Ocular toxicity of desferrioxamine--an example of copper promoted auto-oxidative damage?

Authors:  H Pall; D R Blake; P Winyard; J Lunec; A Williams; P A Good; E E Kritzinger; A Cornish; R C Hider
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

2.  Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.

Authors:  S De Virgiliis; M Congia; M P Turco; F Frau; C Dessi; F Argiolu; R Sorcinelli; A Sitzia; A Cao
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

Review 3.  Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.

Authors:  Maura Di Nicola; Giulio Barteselli; Laura Dell'Arti; Roberto Ratiglia; Francesco Viola
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.